Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma

Cisplatin is ranked as one of the most powerful and commonly prescribed anti-tumor chemotherapeutic agents which improve survival in many solid tumors including non-small cell lung cancer. However, the treatment of advanced lung cancer is restricted due to chemotherapy resistance. Here, we developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Sakhawat, Tahir, Muhammad, Khan, Aamir Ali, Chen, Xue Chai, Ling, Ma, Huang, Yinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429304/
https://www.ncbi.nlm.nih.gov/pubmed/30841620
http://dx.doi.org/10.3390/ijms20051125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429304/
https://www.ncbi.nlm.nih.gov/pubmed/30841620
http://dx.doi.org/10.3390/ijms20051125

Ejemplares similares